Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May 1;14(9):1048-57.

A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness

Affiliations

A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness

M G Guenther et al. Genes Dev. .

Abstract

The corepressor SMRT mediates repression by thyroid hormone receptor (TR) as well as other nuclear hormone receptors and transcription factors. Here we report the isolation of a novel SMRT-containing complex from HeLa cells. This complex contains transducin beta-like protein 1 (TBL1), whose gene is mutated in human sensorineural deafness. It also contains HDAC3, a histone deacetylase not previously thought to interact with SMRT. TBL1 displays structural and functional similarities to Tup1 and Groucho corepressors, sharing their ability to interact with histone H3. In vivo, TBL1 is bridged to HDAC3 through SMRT and can potentiate repression by TR. Intriguingly, loss-of-function TRbeta mutations cause deafness in mice and humans. These results define a new TR corepressor complex with a physical link to histone structure and a potential biological link to deafness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Purification, identification, and verification of SMRT complex components. (a) Pooled SMRT carboxy-terminal monoclonal antibodies are not cross-reactive with N-CoR. In vitro-translated SMRT, N-CoR, or unprogrammed rabbit reticulocyte lysate (RRL) control were subjected to immunoblot analysis with five pooled SMRT monoclonal antibodies or an anti-N-CoR monoclonal antibody. (b) Strategy to obtain SMRT-associated polypeptides. (c) SDS-PAGE and silver-staining analysis of SMRT complex purified as in b from HeLa nuclear extract. SMRT complex components are indicated by arrows. Asterisk denotes a band that was not reproducibly observed in eluates from the SMRT column. (d) Identity of SMRT complex subunits. Peptide sequences obtained by microsequencing are underlined. (e) Immunoblot analysis of SMRT complexes purified independently. Components isolated from nuclear extract or as in b were verified by immunoblot with anti-SMRT, mouse anti-TBL1, anti-HDAC3, anti-Sin3A, and anti-HDAC1. (f) HDAC assay of SMRT purified as in b.
Figure 2
Figure 2
Copurification of SMRT, HDAC3, and TBL1. (a) Multistep purification scheme. (b) Protein elution from Superose 6 column. (c) Immunoblot analysis of Superose 6 column fractions. Fractions were assayed by immunoblot with anti-SMRT, rabbit anti-TBL1, and anti-HDAC3.
Figure 3
Figure 3
In vivo characterization of the SMRT–TBL1–HDAC3 complex. (a) TBL1 and HDAC3 can each associate with SMRT. Extracts of 293T cells transfected with either Myc–TBL1 or Flag–HDAC3 were immunoprecipitated with anti-myc or anti-flag prior to immunoblot with SMRT monoclonal antibody. All inputs represent 1% of each total immunoprecipitation. (b) HDAC3 interacts with both TBL1 and SMRT in vivo. Extracts of 293T cells transfected with Myc–TBL1 and Flag–HDAC3 were immunoprecipitated with anti-flag prior to immunoblot with SMRT or myc polyclonal antibody. (c) TBL1 associates with histone deacetylase enzymatic activity. 293T cells were transfected with either myc-TBL1 or empty vector alone and subjected to immunoprecipitation with anti-myc followed by assay for deacetylase activity.
Figure 4
Figure 4
SMRT–TBL1–HDAC3 interactions in vitro. (a) Schematic representation of the SMRT corepressor indicating repression domains RD1, RD2, and RD3 and nuclear hormone receptor interaction domains ID1 and ID2. (b) GST-pulldown assay using GST fusions of SMRT RD1 [amino acids 1–303 of the full-length SMRT protein (Ordentlich et al. 1999)], SMRT RD2 (amino acids 763–1028), and SMRT RD3 (amino acids 1043–1514) with 35S-labeled HDAC3 and TBL1. (c) Full-length SMRT interacts with HDAC3 in vitro. 35S-labeled HDAC3 was incubated with control (unprogrammed) RRL (lanes 2,3) or unlabeled full-length SMRT translated in RRL (lanes 4,5) and subjected to immunoprecipitation with control IgG or SMRT monoclonal antibody pool. Input lane shows 1% of total. (d) The amino terminus of TBL1 interacts with N-CoR and SMRT. GST-pulldown assay using GST fusions of TBL1 full-length(1–577), amino-terminus (1–211), and carboxy-terminal WD40-repeat domain (211–577) with 35S-labeled SMRT and N-CoR. (e) The SMRT–TBL1–HDAC3 interaction can be recapitulated in vitro. GST-pulldown assay using GST fusion to full-length TBL1 with 35S-labeled HDAC3 in the presence of control RRL (lanes 2,3) or unlabeled SMRT translated in RRL (lanes 4,5).
Figure 5
Figure 5
Role of TBL1 in repression. (a) TBL1 potentiates repression by thyroid hormone receptor. A Gal4–TK-luciferase reporter was cotransfected with either Gal4 DBD, Gal4–TR, or Gal4–TR(V230R) and increasing amounts (black ramps representing 0.25–1.5 μg of DNA) of pCMX–HA–TBL1 into HeLa cells. Fold repression was measured as relative to Gal4 DBD alone and the results of duplicate samples are shown. (b) SMRT recruits TBL1 to TR. GST-pulldown assay using GST fusion to TRβ ligand-binding domain with 35S-labeled TBL1 in the presence of control RRL (lanes 2,3) or unlabeled SMRT translated in RRL (lanes 4,5). (c) TBL1 contains an autonomous repression domain. Gal4–TBL1(1–577), Gal4–TBL1(1–211), and Gal4–TBL1(211–577) were transfected with the Gal4–TK-luciferase reporter and fold repression was measured relative to Gal4 DBD alone. (d) GST–TBL1 interacts with histone H3. HeLa Nuclear extract was incubated with either GST alone or GST–TBL1 and interacting histone H3 visualized by immunoblot.
Figure 6
Figure 6
Role of the core SMRT complex in repression. A model for SMRT-mediated repression indicating the core SMRT–HDAC3–TBL1 complex, with potential repression mechanisms including (1) HDAC activity via HDAC3, (2) Tup1/Groucho-like functions mediated by TBL1, and (3) interactions between SMRT and general transcription factors. These repression functions may be augmented by additional interactions with the mSin3/HDAC1 complex, as well as HDAC4, HDAC5, and HDAC7.

Similar articles

Cited by

References

    1. Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, DePinho RA. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature. 1997;387:49–55. - PubMed
    1. Asahara H, Dutta S, Kao HY, Evans RM, Montminy M. Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol Cell Biol. 1999;19:8219–8225. - PMC - PubMed
    1. Bassi MT, Ramesar RS, Caciotti B, Winship IM, DeGrandi A, Riboni M, Townes PL, Beighton P, Ballabio A, Borsani G. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats. Am J Hum Gen. 1999;64:1604–1616. - PMC - PubMed
    1. Carlson M. Genetics of transcriptional regulation in yeast: Connections to the RNA polymerase II CTD. Annu Rev Cell Dev Biol. 1997;13:1–23. - PubMed
    1. Chen G, Nguyen PH, Courey AJ. A role for Groucho tetramerization in transcription repression. Mol Cell Biol. 1998;18:7259–7268. - PMC - PubMed

Publication types

MeSH terms